The EU has set aside 5 billion the EIC – Accelerator program in 2019-2020. The EIC – Accelerator can provide individual companies support for up to 18 million DKK (grant) and up to 112 million in investment (equity) with the EU as a silent investor. The program will support projects with high risk and very high earning potential. Subsequently, the program will invest the necessary resources to reduce the risk before the ownership interests are sold on to venture capital funds. Biotech companies could use the support to finance validation of technologies, initial clinical trials and so on.
Biopeople and The Greater Copenhagen EU Office invite you to their event, which in one hour gives you a quick introduction to the EIC – Accellerator and concrete experiences with investment from the EU from the biotech company AntibioTx A/S.
26-09-2019 15:00 – 17:00
Maersk Tower, Room 7.15.149 Blegdamsvej 3B 2200 – Copenhagen
15:30 Introduction & Welcome by Per Spindler, Biopeople
15:35 EIC – Accellerator: What support and investment can apply for and what are the differences with the SME instrument by Rasmus Dark, Greater Copenhagen EU Office
16:00 Our experience with investment from the EU: Negotiation, reporting and consequences by Morten Sommer, UNION therapeutics A/ S
16:30 Networking with participants and presenters
Note that the program is in Danish.
Participation is free. Online registration required here.